These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 34561086)

  • 41. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
    Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
    Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of a Mouthwash Containing CHX and CPC in SARS-CoV-2-Positive Patients: A Randomized Controlled Clinical Trial.
    Bonn EL; Rohrhofer A; Audebert FX; Lang H; Auer DL; Scholz KJ; Schuster P; Wenzel JJ; Hiller KA; Buchalla W; Gottsauner JM; Vielsmeier V; Schmidt B; Cieplik F
    J Dent Res; 2023 Jun; 102(6):608-615. PubMed ID: 36942423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mouthrinses and SARS-CoV-2 viral load in saliva: a living systematic review.
    Hernández-Vásquez A; Barrenechea-Pulache A; Comandé D; Azañedo D
    Evid Based Dent; 2022 May; ():1-7. PubMed ID: 35610479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction of SARS-CoV-2 viral load in saliva after rinsing with mouthwashes containing cetylpyridinium chloride: a randomized clinical study.
    Bezinelli LM; Corrêa L; Beyerstedt S; Franco ML; Rangel ÉB; Benítez CG; Hamerschlak N; Pinho JRR; Heller D; Eduardo FP
    PeerJ; 2023; 11():e15080. PubMed ID: 38130922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of Toothpastes on SARS-CoV-2 Viral Load in Saliva.
    Eduardo FP; Corrêa L; Mansur F; Benitez C; Hamerschlak N; Pinho JRR; Heller D; Bezinelli LM
    Int Dent J; 2022 Dec; 72(6):825-831. PubMed ID: 35570015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Do hydrogen peroxide mouthwashes have a virucidal effect? A systematic review.
    Ortega KL; Rech BO; El Haje GLC; Gallo CB; Pérez-Sayáns M; Braz-Silva PH
    J Hosp Infect; 2020 Dec; 106(4):657-662. PubMed ID: 33058941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The efficacy of mouthwashes in reducing SARS-CoV-2 viral loads in human saliva: A systematic review.
    Ziaeefar P; Bostanghadiri N; Yousefzadeh P; Gabbay J; Shahidi Bonjar AH; Ghazizadeh Ahsaie M; Centis R; Sabeti M; Sotgiu G; Migliori GB; Nasiri MJ
    New Microbes New Infect; 2022; 49():101064. PubMed ID: 36530834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Virucidal Activity of Different Mouthwashes against the Salivary Load of SARS-CoV-2: A Narrative Review.
    Garcia-Sanchez A; Peña-Cardelles JF; Salgado-Peralvo AO; Robles F; Ordonez-Fernandez E; Ruiz S; Végh D
    Healthcare (Basel); 2022 Mar; 10(3):. PubMed ID: 35326947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is hydrogen peroxide an effective mouthwash for reducing the viral load of SARS-CoV-2 in dental clinics?
    Burgos-Ramos E; Urbieta IR; Rodríguez D
    Saudi Dent J; 2022 Mar; 34(3):237-242. PubMed ID: 35136326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial.
    Sánchez Barrueco Á; Mateos-Moreno MV; Martínez-Beneyto Y; García-Vázquez E; Campos González A; Zapardiel Ferrero J; Bogoya Castaño A; Alcalá Rueda I; Villacampa Aubá JM; Cenjor Español C; Moreno-Parrado L; Ausina-Márquez V; García-Esteban S; Artacho A; López-Labrador FX; Mira A; Ferrer MD
    Emerg Microbes Infect; 2022 Dec; 11(1):1833-1842. PubMed ID: 35796097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review.
    Lim NA; Teng O; Ng CYH; Bao LXY; Tambyah PA; Quek AML; Seet RCS
    Ann Med; 2022 Dec; 54(1):1488-1499. PubMed ID: 35594333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can povidone iodine gargle/mouthrinse inactivate SARS-CoV-2 and decrease the risk of nosocomial and community transmission during the COVID-19 pandemic? An evidence-based update.
    Chopra A; Sivaraman K; Radhakrishnan R; Balakrishnan D; Narayana A
    Jpn Dent Sci Rev; 2021 Nov; 57():39-45. PubMed ID: 33747261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of Mouth Rinses and Nasal Spray in the Inactivation of SARS-CoV-2: A Systematic Review and Meta-Analysis of
    Idrees M; McGowan B; Fawzy A; Abuderman AA; Balasubramaniam R; Kujan O
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse.
    Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
    J Prosthodont; 2020 Jul; 29(6):529-533. PubMed ID: 32511851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sources of SARS-CoV-2 and Other Microorganisms in Dental Aerosols.
    Meethil AP; Saraswat S; Chaudhary PP; Dabdoub SM; Kumar PS
    J Dent Res; 2021 Jul; 100(8):817-823. PubMed ID: 33977764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of Oral Rinsing with Octenidine Based Solution on SARS-CoV-2 Loads in Saliva of Infected Patients an Exploratory Study.
    Smeets R; Pfefferle S; Büttner H; Knobloch JK; Lütgehetmann M
    Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35564977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Could certain mouthwashes reduce transmissibility of COVID-19?
    Elmahgoub F; Coll Y
    Evid Based Dent; 2021 Jan; 22(2):82-83. PubMed ID: 34172918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Review of Topical Povidone-iodine to Decrease Viral Load of COViD-19.
    Benson KM; Mancini AA; Brodeur MR
    Sr Care Pharm; 2021 May; 36(5):238-241. PubMed ID: 33879284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.